Suggestions
Anil Goyal
Chief Executive Officer, Co-Founder, Board Director at IMMvention Therapeutix, Inc., Co-Founder, OpenDoors Group (a Non-profit to enhance diversity in Biotech), Angel Investor
Anil Goyal is a seasoned biotech industry executive with over 25 years of experience leading and expanding biotechnology companies focused on cutting-edge therapies, technologies, and discovery platforms.
His expertise includes strategic planning, new company establishment, licensing, mergers and acquisitions, as well as fundraising from various sources such as venture capitalists, corporate venture capital, public markets, NIH, and venture philanthropies.
Anil Goyal's educational background is extensive, with studies in Negotiations for Senior Executives from top institutions like Harvard Law School, Harvard Business School, and MIT, along with courses in Clinical Pharmacology, Drug Development Regulation, and Marketing from Tufts University School of Medicine. He also holds a Ph.D. in Microbiology & Molecular Genetics from Rutgers University, an M.S. in Microbiology from the University of Mumbai, and a B.Sc. in Microbiology from the same university.
Throughout his career, Anil Goyal has held key positions in notable biotech organizations, including serving on the Board of Directors at Enzerna Biosciences, being a Co-Founder at OpenDoors Group, and acting as Chief Executive Officer & Board Director at IMMvention Therapeutix, Inc. He has also been a Chief Operating Officer at Ribometrix Inc., CEO/CBO at Biotechnology Companies at OpenDoors Group, LLC, Vice President of Business Development at Heat Biologics, Inc., President, CEO, and Co-Founder at Qualiber, Inc., and Vice President of Business Development at Optherion, Inc., among others.
Anil Goyal has a strong background in various facets of the biotech industry, from management and business development to company operations and strategic decision-making. His wealth of experience in leading and nurturing biotechnology firms makes him a respected figure in the field and a valuable asset to any organization.
Anil Goyal has honed his skills through diverse roles, including Manager of Business Development at Genome Therapeutics Corporation, Senior Manager of Corporate Development at Millennium Pharmaceuticals, and Postdoctoral Fellow positions at the Center for Agriculture and Environment as well as at Merck and Co.
His breadth of experience, combined with a solid educational foundation, positions Anil Goyal as a leader in the biotech sector, capable of driving innovation, fostering growth, and navigating complex challenges within the industry.
